ID: ALA5284897

Max Phase: Preclinical

Molecular Formula: C17H10FN3O2

Molecular Weight: 307.28

Associated Items:

Representations

Canonical SMILES:  O=c1[nH]n2c(=O)c3ccccc3nc2/c1=C/c1ccc(F)cc1

Standard InChI:  InChI=1S/C17H10FN3O2/c18-11-7-5-10(6-8-11)9-13-15-19-14-4-2-1-3-12(14)17(23)21(15)20-16(13)22/h1-9H,(H,20,22)/b13-9-

Standard InChI Key:  DCMYHQMCRQKYSM-LCYFTJDESA-N

Associated Targets(Human)

PTGS2 Tclin COX-1/COX-2 (288 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PTGS2 Tclin Cyclooxygenase-2 (13999 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ALOX5 Tclin Arachidonate 5-lipoxygenase (6568 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 307.28Molecular Weight (Monoisotopic): 307.0757AlogP: 1.22#Rotatable Bonds: 1
Polar Surface Area: 67.23Molecular Species: NEUTRALHBA: 4HBD: 1
#RO5 Violations: 0HBA (Lipinski): 5HBD (Lipinski): 1#RO5 Violations (Lipinski): 0
CX Acidic pKa: 7.43CX Basic pKa: 2.96CX LogP: 2.50CX LogD: 2.25
Aromatic Rings: 4Heavy Atoms: 23QED Weighted: 0.57Np Likeness Score: -1.06

References

1. Ahmadi M, Bekeschus S, Weltmann KD, von Woedtke T, Wende K..  (2022)  Non-steroidal anti-inflammatory drugs: recent advances in the use of synthetic COX-2 inhibitors.,  13  (5.0): [PMID:35685617] [10.1039/d1md00280e]

Source